SEC Form 4 · accession 0001572426-16-000166
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine T Farrell
Officer — VP Operations, General Counsel
Period of report
Mar 3, 2016
Accepted (ET)
Mar 17, 2016 · 12:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 3, 2016 | S | 132 | $3.2701 | D | 0 | I | Nexvet EBT Limited |
| Ordinary SharesF2 | holding | — | — | — | 21,253 | I | Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> | |
| Ordinary Shares | holding | — | — | — | 4,300 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.
- F2The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.